Use of transcriptional profiling to delineate the initial response of mice to intravaginal herpes simplex virus type 2 infection

Viral Immunology

Volumn 26, Issue 3, 2013, Pages 172-179

  Cherpes, Thomas L ^a   Harvey, Stephen A K ^b   Phillips, Jaclyn M ^a   Vicetti Miguel, Rodolfo D ^a   Melan, Melissa A ^b   Quispe Calla, Nirk E ^a   Hendricks, Robert L ^b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; MESSENGER RNA; OLIGONUCLEOTIDE; PATTERN RECOGNITION RECEPTOR; POLYINOSINIC POLYCYTIDYLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EYE INFECTION; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENITAL HERPES; HERPES SIMPLEX; HERPES SIMPLEX ENCEPHALITIS; HERPES SIMPLEX VIRUS 2; IMMUNE RESPONSE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; TISSUE MICROARRAY; VAGINA; VAGINITIS; VIRUS IMMUNITY;

ANIMALS; FEMALE; GENE EXPRESSION PROFILING; HERPES GENITALIS; HERPESVIRUS 2, HUMAN; HOST-PATHOGEN INTERACTIONS; MICE; MICE, INBRED C57BL; MICROARRAY ANALYSIS; TIME FACTORS; VAGINA;

HUMAN HERPESVIRUS 2; MUS; SIMPLEXVIRUS;

EID: 84879160757     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2012.0093     Document Type: Article

References (22)

1. Ashkar, AA, Yao X, Gill N, Sakic D, Patrick AJ, and Rosenthal KL. Toll-Like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA. J Infect Dis 2004;190: 1841-1849
2. Bukowski JF, and Welsh RM. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1. J Immunol 1986;136: 3481-3485
3. Cherpes TL, Melan MA, Kant JA, Cosentino LA, Meyn LA, and Hiller SL. Genital tract shedding of herpes simplex virus type 2 in women: Effects of hormonal contraception, bacterial vaginosis, and vaginal group B Streptococcus colonization. Clin Infect Dis 2005;40:1422-1428
4. Gill N, Chenoweth MJ, Verdu EF, and Ashkar AA. NK cells require type I IFN receptor for antiviral responses during genital HSV-2 infection. Cell Immunol 2011;269:29-37
5. Gill N, Deacon PM, Lichty B, Mossman KL, and Ashkar AA. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of toll-Like receptor ligands correlates with beta interferon production. J Virol 2006;80: 9943-9950
6. Iijima N, Mattei LM, and Iwasaki A. Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissue. Proc Natl Acad Sci USA 2010;108:284-289
7. Johnson KE, Song B, and Knipe DM. Role for herpes simplex virus 1 ICP27 in the inhibition of type I interferon signaling. Virology 2008;374:487-494
8. Kaushic C, Ashkar AA, Reid LA, and Rosenthal KL. Progesterone increases susceptibility and decreases immune responses to genital herpes infection. J Virol 2003;77:4558-4565
9. Lin R, Noyce RS, Collins SE, Everett RD, and Mossman KL. The herpes simplex virus ICP0 RING finger domain inhibits IRF3 and IRF7-mediated activation of interferon-stimulated genes. J Virol 2004;78:1675-1684
10. Lund JM, Hsing L, Pham TT, and Rudensky AY. Coordination of early protective immunity to viral infection by regulatory T cells. Science 2008;320:1220-1224
11. McDermott MR, Smiley BJ, Brais PLJ, Rudzroga H, and Bienenstock J. Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2. J Virol 1984;51:247-253
12. Melchjorsen J, Matikainen S, and Paludan SR. Activation and evasion of innate antiviral immunity by herpes simplex virus. Viruses 2009;1:737-759
13. Murphy JA, Duerst RJ, Smith TJ, and Morrison LA. Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo. J Virol 2003;77:9337-9345
14. Parr EL, Holliday EM, Collard MW, and MB Parr. Observations on recovery from and recurrence of HSV-2 infections in adult mice that were rescued from lethal vaginal infection by antiviral therapy. Arch Virol 2005;150:1885-1902
15. Parr MB, and Parr EL. The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice. J Virol 1999;258:282-294
16. Parr MB, Kepple L, McDermott MR, Drew MD, Bozzola JJ, and Parr EL. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab Invest 1994;70:369-380
17. Peng T, Zhu J, Klock A, Phasouk K, Huang M, Koelle DM, Wald A, and Corey L. Evasion of the mucosal innate immune system by herpes simplex virus type 2. J Virol 2009;83:12559-12568
18. Samarajiwa SA, Forster S, Auchettl K, and Hertzog PJ. INTERFEROME: The database of interferon regulated genes. Nucleic Acids Res 2009;37:D852-D857
19. Shen H, and Iwasaki A. A crucial role for plasmacytoid dendritic cells in antiviral protection by CpG ODN-based vaginal microbicide. J Clin Invest 2006;116:2237-2243
20. Svensson A, Bellner L, Magnusson M, and Erikson K. Role of IFN-A/b signaling in the prevention of genital herpes virus type 2 infection. J Reprod Immunol 2007;74:114-123
21. Verpooten D, Ma Y, Hou S, Yann Z, and He B. Control of TANK-binding kinase 1-mediated signaling by the gamma (1)34.5 protein of herpes virus simplex virus 1. J Biol Chem 2009;284:1097-1105
22. Yokota S, Yokosawa N, Okabayashi T, Suzutani T, Miura S, Jimbow K, and Fujii N. Induction of suppressor of cytokine signaling-3 by herpes virus simplex virus type 1 contributes to inhibition of the interferon signaling pathway. J Virol 2004;78:6282-6286